The effect of oral metformin on insulin sensitivity in insulin-resistant ponies

Kellie Tinworth, Ray C. Boston, Patricia A. Harris, Martin Sillence, Sharanne Raidal, Glenys Noble

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)
97 Downloads (Pure)


Metformin may be an effective therapeutic option for insulin-resistant (I-R) horses/ponies because, in humans, it reportedly enhances insulin sensitivity (SI) of peripheral tissues without stimulating insulin secretion. To determine the effect of metformin on insulin and glucose dynamics in I-R ponies, six ponies were studied in a cross-over design by Minimal Model analysis of a frequently-sampled intravenous glucose tolerance test (FSIGT). Metformin was administered at 15 mg/kg bodyweight (BW), orally, twice-daily, for 21 days to the metformin-treated group. The control group received a placebo. A FSIGT was conducted before and after treatment. The Minimal Model of glucose and insulin dynamics rendered indices describing SI, glucose effectiveness (Sg), acute insulin response to glucose (AIRg) and the disposition index (DI). The body condition score (BCS), BW and cresty neck score (CNS) were also assessed.There was no significant change in SI, Sg, AIRg, DI, BW, BCS or CNS in response to metformin, or over time in the control group. There were no measurable benefits of metformin on SI, consistent with recent work showing that the bioavailability of metformin in horses is poor, and chronic dosing may not achieve therapeutic blood concentrations. Alternatively, metformin may only be effective in obese ponies losing weight or with hyperglycaemia.
Original languageEnglish
Pages (from-to)79-84
Number of pages6
JournalVeterinary Journal
Issue number1
Publication statusPublished - Jan 2012


Dive into the research topics of 'The effect of oral metformin on insulin sensitivity in insulin-resistant ponies'. Together they form a unique fingerprint.

Cite this